We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
+75.98%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
AUM
$226M
AUM Growth
+$50M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
1
Fulcrum Therapeutics
FULC
$288M
$99.2M 43.81%
5,962,202
VYGR icon
2
Voyager Therapeutics
VYGR
$189M
$89.2M 39.37%
6,391,176
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$26.6M 11.75%
3,048,780
NTGN
4
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$11.5M 5.08%
9,741,636

Similar funds

TRV GP III's Q4 2019 Portfolio in Review

As of Q4 2019, TRV GP III held 4 positions worth $226M, up 28% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 0%. TRV GP III opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's ten largest holdings make up 100% of its $226M portfolio in Q4 2019.
  • TRV GP III opened 0 new positions and closed 0 in Q4 2019.
  • TRV GP III's portfolio value rose 28% quarter-over-quarter to $226M.

Based on TRV GP III's 13F filing for Q4 2019, filed 5 Feb 2020.